SELECTION OF A FILLER FOR TABLETS MANUFACTURED WITH DIRECT COMPRESSION METHOD CONTAINING DRY GINGER EXTRACT

Оlena Ruban, Malek Alkhalaf, Nataliia Gerbina

Abstract


The preliminary studies of physico-chemical and pharmaco-technological properties of the dry extract of ginger have determined the need for introduction of different groups of excipients for developing a solid dosage form for the treatment of type II diabetes mellitus.

Aim. To choose the rational filler in the composition of tablets with ginger obtained by direct compression.

Materials and methods. The study object was the dry extract of ginger (DEG) (producer “Megaprom”, Dnepr,Ukraine) and modern excipients for the production of tablets by direct compression: GalenIQ 721 (BENEO-Palatinit Gmb), Flowlac 100 (Meggle Co.), Tablettose 80 (Meggle Co.), Farmaxx (Merck), Microcelac 100 (Meggle Co.), Vivapur 112 and 102 (JRS Pharm), Prosolv HD 90, Prosolv SMCC 50 (JRS Pharm) manufactured in Germany. Pharmaco-technological and physico-chemical properties of the samples were studied according to conventional methods of the State Pharmacopoeia of Ukraine.

Results and discussion. According to the results of the crystallographic analysis, the ability to the moisture absorption, resistance to crushing, disintegration time, fluidity indicators, angle of repose and bulk volume the effect of modern excipients on physicochemical and pharmaco-technological properties of the dry extract of ginger has been studied.

Conclusions. According to the results of microscopic analysis, it has been found, that the rational fillers are GalenIQ 721, Prosolv HD 90, Prosolv SMCC 50, Vivapur 102 and Vivapur 112, as they provide a uniform system and the necessary resistance to destruction. The study of the kinetics of the moisture absorption has shown that addition of the fillers significantly reduces the increase in moisture compared to the dry extract. The mixture with GalenIQ 721 has the lowest parameters of moisture absorption at a relative air humidity of 45 %, 75 % and 100 %. In accordance with the results of the pharmaco-technological studies, it has been found that addition of GalenIQ 721 leads to improved flowability, disintegration, settling qualities; it indicates the feasibility of its inclusion into the composition of the solid dosage form.


Keywords


type II diabetes mellitus; phytotherapy; dry extract; ginger; Galen IQ 721; excipients; fillers; tablets; direct compression

Full Text:

PDF

References


Zheng, Y., Ley, S. H., Hu, F. B. (2017). Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nature Reviews Endocrinology, 14 (2), 88–98. doi: http://doi.org/10.1038/nrendo.2017.151

Lotfy, M., Adeghate, J., Kalasz, H., Singh, J., Adeghate, E. (2016). Chronic Complications of Diabetes Mellitus: A Mini Review. Current Diabetes Reviews, 13 (1), 3–10. doi: http://doi.org/10.2174/1573399812666151016101622

Okur, M. E., Karantas, I. D., Siafaka, P. I. (2017). Diabetes Mellitus: A Review on Pathophysiology, Current Status of Oral Pathophysiology, Current Status of Oral Medications and Future Perspectives. ACTA Pharmaceutica Sciencia, 55 (1), 61–82. doi: http://doi.org/10.23893/1307-2080.aps.0555

Fareed, M., Salam, N., Khoja, A. T., Mahmoud, M. A., Ahamed, M. (2017). Life Style Related Risk Factors of Type 2 Diabetes Mellitus and Its Increased Prevalence in Saudi Arabia: A Brief Review. International Journal of Medical Research & Health Sciences, 6, 125–132.

Governa, P., Baini, G., Borgonetti, V., Cettolin, G., Giachetti, D., Magnano, A. et. al. (2018). Phytotherapy in the Management of Diabetes: A Review. Molecules, 23 (1), 105–127. doi: http://doi.org/10.3390/molecules23010105

Bansode, T. S., Salalkar, B. K. (2017). Phytotherapy: Herbal medicine in the management of Diabetes mellitus. Plant Science Today, 4 (4), 161–165. doi: http://doi.org/10.14719/pst.2017.4.4.347

Ilkhanizadeh, B., Shirpoor, A., Khadem Ansari, M. hasan, Nemati, S., Rasmi, Y. (2016). Protective Effects of Ginger (Zingiber officinale) Extract against Diabetes-Induced Heart Abnormality in Rats. Diabetes & Metabolism Journal, 40 (1), 46–53. doi: http://doi.org/10.4093/dmj.2016.40.1.46

Karimi, A., Majlesi, M., Rafieian-Kopaei, M. (2015). Herbal versus synthetic drugs; beliefs and facts. Journal of Nephropharmacology, 4, 27–30.

Akinyemi, O., Oyewole, S. O., Jimoh, K. A. (2018). Medicinal plants and sustainable human health: a review. Horticulture International Journal, 2 (4), 194–195. doi: http://doi.org/10.15406/hij.2018.02.00051

Dhanik, J., Nand, N. A. V. (2017). A Review on Zingiber officinale. Journal of Pharmacognosy and Phytochemistry, 5, 174–184.

Onianwah, I., Stanley, H. O. (2018). Comparative Study of the Antibacterial Activity of the Underground Stem of Ginger (Zingiber officinale) and the Bulb of Garlic (Allium sativum) on Selected Aerobic Bacterial Species. Electronic Journal of Biology, 14, 18–21.

Kononenko, N. М., Chikitkina, V. V., Sorokina, M. V., Alkhalaf, M. W. (2018). Experimental rationale of selection of the hypoglicemic dose of ginger dry extract on normoglycemic rats. Farmatsevtychnyi Zhurnal, 1-2, 68–77. doi: http://doi.org/10.32352/0367-3057.1-2.18.08

Hassan, N. A., Karunakaran, R., Sankar, A. U., Aye, K. M. (2016). Anti-Diabetic Effect of Zingiber Officinale on Sprague Dawley Rats. International Journal of Pharmacognosy and Phytochemical Research, 8, 1940–1943.

Alkhalaf, M. V., Ruban, О. A., Gerbina, N. A., Masliy, Yu. S. (2018). Studies of Physicochemical and Pharmacotechnological Properties of Zingiber Officinale Dry Extract. Journal of Pharmaceutical Science and Research, 10 (1), 5–7.

Pedro, I. D. R., Brandão, I. C. C., Palhares de Souza, G. M. C., Carneiro, G. (2017). Development of tablet formulations of calcium carbonate by direct compression. Journal of applied pharmaceutical science, 4, 12–20.

Olorunsola, E. O., Akpan, G. A., Adikwu, M. U. (2017). Evaluation of Chitosan-Microcrystalline Cellulose Blends as Direct Compression Excipients. Journal of Drug Delivery, 2017, 1–8. doi: http://doi.org/10.1155/2017/8563858

Rowe, R. C., Sheskey, P. J., Cook, W. G., Fenton, M. E. (2012). Handbook of Pharmaceutical Excipients. Pharmaceutical Press and American Pharmacists Association, 1033.

Teh, T. L. C., Abdul Majid, F. A., Iqbal, M. C. (2017). Development of DiabecineTM Tablet and Confirmation of Its Physical Properties and Pharmaceutical Safety Analysis. Sains Malaysia, 46 (4), 597–604. doi: http://doi.org/10.17576/jsm-2017-4604-12

Zhydkova, T. N., Krutskykh, T. V. (2015). Some aspects of developing the production technology for combined tablets based on B vitamins. News Of Pharmacy, 4 (84), 26–30. doi: http://doi.org/10.24959/nphj.15.2055

Derzhavna Farmakopeia Ukrainy. Vol. 1 (2015). Kharkiv: Derzhavne pidpryiemstvo «Ukrainskyi naukovyi farmakopeinyi tsentr yakosti likarskykh zasobiv», 1128.

Filimonovа, A. V., Tretyakova, Y. A., Gavrilov, A. S., Soloduhina, L. A., Riabinin, A. E. (2016). Validol sugafree tablets: development of technology and production. Belgorod State University Scientific bulletin. Meditsina. Farmatsiya, 31 (16), 194–200.

Zaychenko, V., Ruban, O., Maslii, Y., Gerbina, N. (2018). Physico-chemical and pharmaco-technological research at a substantiation of rational composition and technology of suppositories «indoxam». ScienceRise: Pharmaceutical Science, 5 (15), 17–23. doi: http://doi.org/10.15587/2519-4852.2018.146500

Kovalevska, I. V., Borko, Ye. A., Poluian, S. M. (2019). A study of the influence of solvents on crystallographic characteristics of local anesthetics. Annals of Mechnikov Institute, 1, 17–22.




DOI: http://dx.doi.org/10.21303/2504-5679.2019.00904

Refbacks

  • There are currently no refbacks.




Copyright (c) 2019 Оlena Ruban, Malek Alkhalaf, Nataliia Gerbina

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

ISSN 2504-5679 (Online), ISSN 2504-5660 (Print)